Increased Funding
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
2010 Commonwealth Games ~ 2010 Nobel Prizes ~ Sachin Tendulkar ~ Rajasthan Royals ~ Kings XI Punjab ~ Sushil Kumar ~ Deepika Kumari ~ Somdev Devvarman ~ HR Bhardwaj
Home / India News / 2007 / January / January 11, 2007
Increased Funding for Life Sciences and Strong Industrial Partnerships Crucial to Develop Knowledge-based Economy in Europe

Top News

144 Section in Hyderabad ahead of Ayodhya verdict

Manmohan Singh to campaign in Bihar today

FBI failed to act on Headley's wife's terror link expose 3 yrs before Mumbai attacks

Craven's horror flicks 'were inspired by real stories'

RBI will intervene if inflows turn lumpy: Subbarao

Enforcement Directorate issues 'Look Out Circular' against Lalit Modi

Now, laser technology that destroys tumours using heat

Waist size, not BMI can foretell cardiovascular risk in children

Increased Funding for Life Sciences and Strong Industrial Partnerships Crucial to Develop Knowledge-based Economy in Europe

Mumbai, Maharashtra, India

In recent years, Europeans have become increasingly optimistic about life science and biotechnology research. This is due to significant opportunities offered by life sciences and biotechnology in healthcare applications. Underpinned by these trends, Europe is witnessing several changes in the funding mechanisms to ensure proper utilisation of funds for life sciences research projects.

"In recent years, basic life sciences research has witnessed unprecedented advances," notes Frost & Sullivan (http://www.pharma.frost.com) Industry Analyst Sylvia Miriyam Findlay in a new study on Life Sciences Funding in Europe (2006) - Phase I. "The human genome project, 'omics' research and the transition towards integrating systems biology will initiate a paradigm shift in the European life sciences funding landscape."

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Life Sciences Funding in Europe (2006)- Phase I (M05F- 52), send an e-mail to Shwetha Thomas - Corporate Communications at sthomas@frost.com with your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information through email upon receipt of the above information.

The European Commission has undertaken several initiatives to exploit growth opportunities in the life sciences and biotechnology sector. The increasing trend of support for research in the areas of life sciences and biotechnology has been reflected in the implementation of the Sixth Framework Programme (FP6). This programme aims to foster competitiveness, innovation and scientific excellence through integration and coordination of research efforts at all levels.

While Europe possesses a robust scientific base, harnessing the full potential of life sciences and biotechnology is essential. To this end, manpower will need to be channeled effectively to optimise the benefits of the life sciences and biotechnological revolution.

Moreover, funding challenges obstruct the move towards making Europe a knowledge-based economy. The diverse nature of funding efforts in Europe complicates the ultimate aim of weaving a seamless fabric of a unified research community across the region.

"Improper consolidation and channeling of various public funds is the primary issue confronting life sciences funding," explains Ms. Findlay. "Hence, efficient utilisation of funds and heightened public involvement is of critical importance. A constructive political and societal collaboration is vital to increase the involvement of public investment for basic research in Europe."

Basic research funding needs to focus primarily on the integration of research activities at a pan-European level. In addition, incubatory researches across Europe have to be incorporated in the funding agenda. Such centres of innovation hold immense potential for innovations in life sciences.

While the European knowledge base is immense, it is inefficient in exploiting research outcomes. This highlights the importance of the increased participation of small and medium-sized enterprises (SME). The European Commission has taken various initiatives to increase SME participation. Strong industrial partnerships are the key to maximise knowledge and expertise, which will result in innovation that can create a knowledge-based economy in Europe.

Life Sciences Funding in Europe (2006) - Phase I is part of the Pharmaceuticals and Biotechnology Subscription, which also includes research in the following markets: life sciences funding in the United Kingdom, Germany and France. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com.

Life Sciences Funding in Europe (2006) - Phase I
M05F- 52

Shwetha Thomas, Corporate Communications - South Asia & Middle East, Frost & Sullivan, + 91 (022) 4001 3429 sthomas@frost.com

Radhika Menon Theodore, Corporate Communications - Europe, Frost & Sullivan, + 91 (044) 4204 4541 rmtheodore@frost.com

Source: Frost & Sullivan (Business Wire India)

Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.

India News / Press Releases on January 11, 2007

Infosys Technologies Q3 Revenues Grew Sequentially By 5.9%
Business Wire India

Greater Modularisation to Drive European Powertrain Modules and Systems Market
Business Wire India

Mastek Group Oct-Dec 2006 Quarter Income up 20%, PAT up 35%
Business Wire India

Wipro Technologies Assessed at Level 5 for CMMI V 1.2 Across Offshore and Onsite Development Centers
Business Wire India

Increased Funding for Life Sciences and Strong Industrial Partnerships Crucial to Develop Knowledge-based Economy in Europe
Business Wire India

Tech Mahindra to set up 3000 seater Software Development Centre at Hyderabad
Ad-Factors PR

Stock Settlement NSE completes its 1729th Normal Settlement
National Stock Exchange of India Limited

Stock Settlement News about Omax Autos Limited
National Stock Exchange of India Limited

Stock Settlement Market-wide Position Limit in IFCI & NAGARFERT
National Stock Exchange of India Limited

Bombay Stock Exchange ICDM Turnover
Bombay Stock Exchange

Also see International News / Press Releases on January 11, 2007

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us